| Literature DB >> 18072243 |
Lukás Palek1, Jaroslav Dvorák, Michaela Svobodová, Vladimír Buchta, Josef Jampílek, Martin Dolezal.
Abstract
This paper describes preparation and biological evaluation of pyrazinamide analogues. Pyrazinamide with its simple structure gives a good opportunity for further modification regarding an increase of its antimycobacterial activity. We prepared a series of compounds derived from pyrazine-2,5-dicarbonitrile with arylamino substitution in position 3. All compounds were assayed in vitro against major Mycobacterium and various Fungi species. The best activity was found in 3-{[3-(trifluoromethyl)phenyl]amino}pyrazine-2,5-dicarbonitrile 11 with the value of 6.25 micromol(-1) against M. tuberculosis H(37)Rv and moderate activity against minor Mycobacterium pathogens.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18072243 DOI: 10.1002/ardp.200700119
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751